Medtronic PLC
NYSE:MDT

  • LAST PRICE
    88.1200
  • TODAY'S CHANGE (%)
    -1.9900 (-2.2084%)
  • Bid / Lots
    88.1200/ 5
  • Ask / Lots
    88.7500/ 1
  • Open / Previous Close
    89.4900 / 90.1100
  • Day Range
    87.7000
    89.5000
  • 52 Week Range
    69.3200
    92.6799
  • Volume
    7,077,443

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Medical Equipment, Supplies & Distribution Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
MDT
Medtronic PLC
115.6B
29.6x
-4.17%
SYK
Stryker Corp
140.7B
39.6x
+9.49%
BDX
Becton Dickinson and Co
69.4B
45.3x
+11.04%
ABT
Abbott Laboratories
203.2B
35.0x
+18.64%
IDXX
IDEXX Laboratories Inc
34.7B
41.8x
+18.62%
BAX
Baxter International Inc
18.4B
-117.6x
---
As of 2024-11-07

Company Information

Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.

Contact Information

Headquarters
Building Two Parkmore Business Park WestDUBLIN, Ireland 1
Phone
---
Fax
---

Executives

Chief Executive Officer, Director
Geoffrey Martha
Interim Chief Financial Officer
Gary Corona
Executive Vice President, General Counsel, Corporate Secretary
Ivan Fong
Executive Vice President, President - Medical Surgical Portfolio and Surgical Operating Unit
Michael Marinaro
Executive Vice President and President - Cardiovascular Portfolio
Sean Salmon

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$115.6B
Revenue (TTM)
$32.6B
Shares Outstanding
1.3B
Dividend Yield
3.18%
Annual Dividend Rate
2.8000 USD
Ex-Dividend Date
09-27-24
Pay Date
10-11-24
Beta
0.85
EPS
$2.97
Book Value
$38.29
P/E Ratio
29.6x
Price/Sales (TTM)
3.5
Price/Cash Flow (TTM)
17.5x
Operating Margin
15.82%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.